Skip to main content
. 2022 Jan 14;3(1):1–10. doi: 10.37349/etat.2022.00067

Figure 1.

Figure 1.

Mechanism of action of ADCs. (1) Circulating ADCs bind to target antigens on the myeloma cell via the monoclonal antibody portion; (2) the ADCs are endocytosed in endosomes; (3) ADCs are then degraded in lysosomes releasing the conjugated cytotoxic payload (toxin, chemotherapy agent, radioisotope, etc.); (4) the cytotoxic payload exerts (deoxyribonucleic acid) DNA damaging effects in the nucleus resulting in cell death; (5) the cytotoxic payload exerts its effects in the cytoplasm via microtubular polymerization and inhibition causing apoptosis